Cardinal Health Expands Higher-Growth Services After Health Care Lags 7%
William Blair launched coverage of Cardinal Health with an Outperform rating, highlighting its durable pharma-distribution franchise and specialty-led growth initiatives. Investors are awaiting Q3 March-quarter estimates and noting Cardinal’s expansion into higher-growth services after the health-care sector underperformed by over 7% while technology soared above 20% in the prior quarter.
1. William Blair Outperform Rating
Investment firm William Blair initiated coverage of Cardinal Health with an Outperform rating, citing the company’s durable pharmaceutical-distribution franchise and potential upside from specialty-led services.
2. Q3 Earnings Estimates
Analysts are tracking top-line and bottom-line consensus estimates for the quarter ended March, along with forecasts for key metrics such as segment sales, margin trends and free cash flow to gauge performance.
3. Specialty Services Expansion
Cardinal Health is broadening its service offerings beyond traditional distribution, moving into higher-growth areas such as clinical trial logistics support and data-driven supply chain solutions to enhance margins.
4. Sector Performance Context
Health-care stocks fell more than 7% last quarter while technology surged over 20%, leading investors to view Cardinal Health as a defensive, non–AI-exposed portfolio hedge given its stable fundamentals.